089Pharm GmbH
- Legal form
- GmbH
- Seat
- München, Germany
Based on the notices and sources Inteliwert covers; not a complete record. Last checked 5 October 2026.
Identifiers
As the covered sources state them.
- Register entry
- HRB 280685
Track record in public tenders
Awards in the covered notices over the last 36 months, per CPV division.
| CPV division | Awards | Award value (excl. VAT) | Buyers | Repeat buyers | First award | Last award |
|---|---|---|---|---|---|---|
| 33 Medical equipments, pharmaceuticals and personal care products | 6 | — | 1 | 1 | 5 October 2026 | 5 October 2026 |
Awards
- Ersatzkassen-Generika Nr. 31 (Bekanntmachung vergebener Aufträge)Buyer: Techniker Krankenkasse · Awarded: 5 October 2026 · CPV 33600000
- Ersatzkassen-Generika Nr. 31 (Bekanntmachung vergebener Aufträge)Buyer: Techniker Krankenkasse · Awarded: 5 October 2026 · CPV 33600000
- Ersatzkassen-Generika Nr. 31 (Bekanntmachung vergebener Aufträge)Buyer: Techniker Krankenkasse · Awarded: 5 October 2026 · CPV 33600000
- Ersatzkassen-Generika Nr. 31 (Bekanntmachung vergebener Aufträge)Buyer: Techniker Krankenkasse · Awarded: 5 October 2026 · CPV 33600000
- Ersatzkassen-Generika Nr. 31 (Bekanntmachung vergebener Aufträge)Buyer: Techniker Krankenkasse · Awarded: 5 October 2026 · CPV 33600000
- Ersatzkassen-Generika Nr. 31 (Bekanntmachung vergebener Aufträge)Buyer: Techniker Krankenkasse · Awarded: 5 October 2026 · CPV 33600000
Certifications and prequalification
No certification or prequalification found in the covered sources.
A certification missing here is unknown, not absent.
Website and LinkedIn
- Website
- http://089pharm.de/declared in a notice
Open tenders that might fit
Possible match based on public information
Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances.
-
OpenTenderEstablished supplier
Open house Arzneimittelrabattverträge Rituximab, ATC L01FA01
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 3 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 3 Nov 2026
- 6 awards in this field in 36 months, from 1 buyer Evidence · checked 3 Nov 2026
Last checked 27 Oct 2026, 04:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
Open house Arzneimittelrabattverträge Pridinol, ATC M03BX03
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 3 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 3 Nov 2026
- 6 awards in this field in 36 months, from 1 buyer Evidence · checked 3 Nov 2026
Last checked 27 Oct 2026, 04:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
Open house Arzneimittelrabattverträge Melatonin, ausgenommen Retardtabletten in der Wirkstärke 2mg, ATC N05CH01
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 3 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 3 Nov 2026
- 6 awards in this field in 36 months, from 1 buyer Evidence · checked 3 Nov 2026
Last checked 27 Oct 2026, 04:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
Open house Arzneimittelrabattverträge Trastuzumab, zur subkutanen Anwendung, ATC L01FD01
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 3 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 3 Nov 2026
- 6 awards in this field in 36 months, from 1 buyer Evidence · checked 3 Nov 2026
Last checked 27 Oct 2026, 04:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
Open house Arzneimittelrabattverträge Teduglutid, ATC A16AX08
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 3 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 3 Nov 2026
- 6 awards in this field in 36 months, from 1 buyer Evidence · checked 3 Nov 2026
Last checked 27 Oct 2026, 04:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
Open house Arzneimittelrabattverträge Flupentixol, ATC N05AF01
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 3 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 3 Nov 2026
- 6 awards in this field in 36 months, from 1 buyer Evidence · checked 3 Nov 2026
Last checked 27 Oct 2026, 04:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
Open house Arzneimittelrabattverträge Chlortalidon, ATC C03BA04
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 3 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 3 Nov 2026
- 6 awards in this field in 36 months, from 1 buyer Evidence · checked 3 Nov 2026
Last checked 27 Oct 2026, 04:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
Open house Arzneimittelrabattverträge Apixaban, ATC B01AF02
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 3 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 3 Nov 2026
- 6 awards in this field in 36 months, from 1 buyer Evidence · checked 3 Nov 2026
Last checked 27 Oct 2026, 04:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
Open house Arzneimittelrabattverträge Indacaterol und Glycopyrroniumbromid, ATC R03AL04
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 3 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 3 Nov 2026
- 6 awards in this field in 36 months, from 1 buyer Evidence · checked 3 Nov 2026
Last checked 27 Oct 2026, 04:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Pankreatin (ATC-Code nach WHO: A09AA02)
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 4 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 4 Nov 2026
- 6 awards in this field in 36 months, from 1 buyer Evidence · checked 4 Nov 2026
Last checked 27 Oct 2026, 01:30 (UTC+01:00)Official notice
Is this your company?
Send corrections, or ask us to remove the profile, to hello@inteliwert.com. You can also ask that the company never be tagged on LinkedIn.
About this profile
Each fact on this page shows its source: a public notice, an open-data register (GLEIF, Wikidata) or the company’s own website. Inteliwert does not rate companies and does not judge eligibility, fit or chances.
Based on the notices and sources Inteliwert covers; not a complete record.
Last checked 5 October 2026.